13th Product Selection & Pipeline Optimization for Generics 2020

The 13th Product Selection & Pipeline Optimization for Generics 2020 is a conference focused on best tactics and techniques for positioning portfolios to achieve compliance and overcome the current regulatory unknowns in the generics industry.

Key Topics

• Strategic partnership and licensing agreements to maximize portfolio capacity and ROI
• Product selection framework to enhance performance in line with portfolio initiatives
• Portfolio management to ensure and maintain speed to market
• Pproduct rationalization process to predict product viability and success
• Keep pace with the fast-paced generics market to achieve a competitive advantage and market exclusivity

Who should Attend

Vice Presidents, Senior Vice Presidents, Senior Managers and Directors from generic and branded pharmaceutical companies and API companies responsible for:

• Business Development
• Portfolio and Project Management
• Intellectual Property / General Counsel
• Regulatory Affairs
• Biologics / Biosimilars
• Generics (development)
• Supply Chain
• Patents / Patent Litigation
• Quality